table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
infections other than COVID-19
anti-inflammatoty and immuno-therapy
Immunostimulants drugs
convalescent plasma treatment Hung IRC002 Study Team IRC005 Study Team INSIGHT FLU-IVIG ...

0 studies excluded by filtering options 1

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons